Thrombolysis With Recombinant Non-immunogenic Staphylokinase vs Surgery in Patients With Acute Limb Ischemia FORAT Trial

NCT05372718 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

170

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Limb Ischemia

Interventions

DRUG: Recombinant non-immunogenic staphylokinase (Fortelyzin®)
PROCEDURE: surgical methods of treatment

Sponsor

Supergene, LLC